Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

China flag China · Delayed Price · Currency is CNY
6.28
+0.03 (0.48%)
Apr 29, 2026, 3:00 PM CST
-16.04%
Market Cap 10.43B
Revenue (ttm) 15.90B
Net Income (ttm) 978.89M
Shares Out 1.66B
EPS (ttm) 0.59
PE Ratio 10.66
Forward PE 7.48
Dividend 0.38 (6.08%)
Ex-Dividend Date Jun 23, 2025
Volume 19,268,100
Average Volume 24,394,439
Open 6.21
Previous Close 6.25
Day's Range 6.21 - 6.34
52-Week Range 6.21 - 8.55
Beta 0.37
RSI 28.76
Earnings Date Apr 25, 2026

About SHA:600866

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroyi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1964
Employees 9,293
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600866
Full Company Profile

Financial Performance

In 2025, SHA:600866's revenue was 15.90 billion, a decrease of -8.27% compared to the previous year's 17.33 billion. Earnings were 978.89 million, an increase of 3.79%.

Financial Statements

News

There is no news available yet.